655 related articles for article (PubMed ID: 27220658)
1. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
2. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
[TBL] [Abstract][Full Text] [Related]
3. Association of irisin and FNDC5 rs16835198 G>T gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy. An Egyptian pilot study.
Khidr EG; Ali SS; Elshafey MM; Fawzy OA
Gene; 2017 Aug; 626():26-31. PubMed ID: 28479383
[TBL] [Abstract][Full Text] [Related]
4. Lower circulating irisin is associated with type 2 diabetes mellitus.
Liu JJ; Wong MD; Toy WC; Tan CS; Liu S; Ng XW; Tavintharan S; Sum CF; Lim SC
J Diabetes Complications; 2013; 27(4):365-9. PubMed ID: 23619195
[TBL] [Abstract][Full Text] [Related]
5. Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus.
Elizondo-Montemayor L; Gonzalez-Gil AM; Tamez-Rivera O; Toledo-Salinas C; Peschard-Franco M; Rodríguez-Gutiérrez NA; Silva-Platas C; Garcia-Rivas G
Mediators Inflamm; 2019; 2019():6737318. PubMed ID: 31015797
[TBL] [Abstract][Full Text] [Related]
6. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study.
Sahin-Efe A; Upadhyay J; Ko BJ; Dincer F; Park KH; Migdal A; Vokonas P; Mantzoros C
Metabolism; 2018 Feb; 79():24-32. PubMed ID: 29108900
[TBL] [Abstract][Full Text] [Related]
7. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
8. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
9. The relationship between circulating irisin levels and endothelial function in lean and obese subjects.
Hou N; Han F; Sun X
Clin Endocrinol (Oxf); 2015 Sep; 83(3):339-43. PubMed ID: 25382211
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery.
Ebert T; Stepan H; Schrey S; Kralisch S; Hindricks J; Hopf L; Platz M; Lossner U; Jessnitzer B; Drewlo S; Blüher M; Stumvoll M; Fasshauer M
Cytokine; 2014 Feb; 65(2):153-8. PubMed ID: 24355429
[TBL] [Abstract][Full Text] [Related]
11. Circulating Serum Myonectin Levels in Obesity and Type 2 Diabetes Mellitus.
Li Z; Yang YL; Zhu YJ; Li CG; Tang YZ; Ni CL; Chen LM; Niu WY
Exp Clin Endocrinol Diabetes; 2021 Jul; 129(7):528-534. PubMed ID: 31340393
[TBL] [Abstract][Full Text] [Related]
12. SNPs in FNDC5 (irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjects.
Al-Daghri NM; Mohammed AK; Al-Attas OS; Amer OE; Clerici M; Alenad A; Alokail MS
Lipids Health Dis; 2016 Mar; 15():54. PubMed ID: 26968837
[TBL] [Abstract][Full Text] [Related]
13. Relation of serum irisin level with metabolic and antropometric parameters in obese children.
Çatlı G; Küme T; Tuhan HÜ; Anık A; Çalan ÖG; Böber E; Abacı A
J Diabetes Complications; 2016; 30(8):1560-1565. PubMed ID: 27539885
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
15. Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes.
Liu J; Hu Y; Zhang H; Xu Y; Wang G
J Diabetes Complications; 2016; 30(8):1555-1559. PubMed ID: 27503404
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index.
Stengel A; Hofmann T; Goebel-Stengel M; Elbelt U; Kobelt P; Klapp BF
Peptides; 2013 Jan; 39():125-30. PubMed ID: 23219488
[TBL] [Abstract][Full Text] [Related]
17. Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study.
Saadeldin MK; Elshaer SS; Emara IA; Maged M; Abdel-Aziz AK
PLoS One; 2018; 13(11):e0206761. PubMed ID: 30403705
[TBL] [Abstract][Full Text] [Related]
18. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.
Moreno-Navarrete JM; Ortega F; Serrano M; Guerra E; Pardo G; Tinahones F; Ricart W; Fernández-Real JM
J Clin Endocrinol Metab; 2013 Apr; 98(4):E769-78. PubMed ID: 23436919
[TBL] [Abstract][Full Text] [Related]
19. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents.
Jang HB; Kim HJ; Kang JH; Park SI; Park KH; Lee HJ
Metabolism; 2017 Aug; 73():100-108. PubMed ID: 28732566
[TBL] [Abstract][Full Text] [Related]
20. Irisin levels in the progression of diabetes in sedentary women.
Duran ID; Gülçelik NE; Ünal M; Topçuoğlu C; Sezer S; Tuna MM; Berker D; Güler S
Clin Biochem; 2015 Dec; 48(18):1268-72. PubMed ID: 26234637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
